Early day motion tabled by primary sponsor Alan Meale (Labour), on Monday, 14 December 2015, in the House of Commons. It is signed by 25 members in total.
RESEARCH AND DEVELOPMENT AND NEW MEDICINES
That this House is aware that the World Health Organisation (WHO) is shortly to discuss reforms of the research and development of medicines worldwide; notes that examples of failures in medicine include lack of new treatments for conditions such as tuberculosis and other so-called diseases of poverty, and that those suffering life threatening conditions like cancer being unable to afford the treatments needed to survive; and further notes the WHO has created a consultative export group (CEG) whose remit is to prepare a new international agreement which will create alternatives to market-only based incentives for pharmaceutical companies to produce new medicines, prioritise health research according to need rather than profit and establish a pooled fund for research and development to be financed by a levy of 0.01 per cent of gross domestic product to develop new treatments.
Secondary information
- Type
- Early day motion
- Reference
- 867
- Session
- 2015-16
- Other sponsors
- David Crausby
- Geraint Davies
- Ian Lavery
- Ian Mearns
- Grahame Morris
- Subjects
- Diseases Innovation Medicine
- Link
- View this Early day motion on www.parliament.uk
Librarians' tools
- Timestamp
- 2022-10-09 18:40:31 +0100
- URI
- http://data.parliament.uk/edms/48655
- In Indexing
- http://indexing.parliament.uk/Content/Edit/1?uri=http://data.parliament.uk/edms/48655
- In Solr
- https://search.parliament.uk/claw/solr/?id=http://data.parliament.uk/edms/48655